Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Lymphoma 306Lymphoma, Follicular 268Lymphoma, Non-Hodgkin 170Leukemia 138Hodgkin Disease 135Multiple Myeloma 130Leukemia, Lymphocytic, Chronic, B-Cell 110Lymphoma, Large B-Cell, Diffuse 108Leukemia, Myeloid, Acute 98Neoplasms 83Lymphoma, Mantle-Cell 70Burkitt Lymphoma 70Myelodysplastic Syndromes 64Breast Neoplasms 62Lymphoma, T-Cell, Cutaneous 60Lymphoma, B-Cell, Marginal Zone 59Myeloproliferative Disorders 50Mycosis Fungoides 50Motor Activity 49Lymphoma, Large-Cell, Immunoblastic 47Sezary Syndrome 44Neoplasms, Plasma Cell 42Hematologic Neoplasms 41Dementia 41Primary Myelofibrosis 39Leukemia, Myeloid, Chronic-Phase 38Leukemia, Myeloid, Accelerated Phase 38Congenital Abnormalities 38Recurrence 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × B-cell Malignancies × Lymphoid × Clear all
NCT07065279 2025-07-15

JY231(JY231) Injection for the Treatment of R/R B-cell Malignancies

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

Phase NA Recruiting
36 enrolled
Lymphoid

B-cell Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡